Interstitial implantation of 125Ⅰ seeds for stage Ⅳ pancreatic cancer
10.3760/cma.j.issn.1674-6090.2009.02.008
- VernacularTitle:放射性粒子治疗Ⅳ期胰腺癌
- Author:
Zhongwen LV
;
Baodong GAI
;
Dongyan YANG
- Publication Type:Journal Article
- Keywords:
125Ⅰodine;
Pancreatic cancer;
Brachytherapy;
Clinical staging
- From:
Journal of Endocrine Surgery
2009;3(2):95-96,119
- CountryChina
- Language:Chinese
-
Abstract:
Objective Subjective to identify the significance of interstitial implantation of 125Ⅰ seeds in stage Ⅳ pancreatic cancer patients.Methods Retrospectively analysis the clinical datum of 18 cases of stage Ⅳ pancreatic cancer patients treated with the 125Ⅰ seeds implantation, and observe the pain relief rate and the average survival period, then compare with the bulk of domestic statistical datum.Results The rate of easement of pain was 70.6% (12/17) , and the mean time begin to relieve was 2.9 days .The life span after the operation was be-tween 2.5 and 11.5 months , and 5.2 months on average,which is longer conspicuously than the statistics of the past.Conclusions The methods of interstitial implantation of 125Ⅰ seeds can upgrade the quality of the life and living efficiently of stage Ⅳ pancreatic cancer patients.
